Rep. Cisneros filed dozens of trades at once, rotating into power and medical devices
As seen on the 24/7 Wall St. homepage on September 10, 2026.
- AMD Advanced Micro Devices, Inc. (AMD)Partial sell$1K – $15KAug 18
- AGIO 150 Main Street Trust > Bank of America Agios Pharmaceuticals, Inc. - Common StoBuy$1K – $15KAug 20
- APH 150 Main Street Trust > Bank of America Amphenol Corporation Common Stock (APH)Buy$1K – $15KAug 18
- APG 150 Main Street Trust > Bank of America APi Group Corporation Common Stock (APG)Buy$1K – $15KAug 4
- APP 150 Main Street Trust > Bank of America Applovin Corporation - Class A Common StPartial sell$1K – $15KAug 18
- AORT 150 Main Street Trust > Bank of America Artivion, Inc. Common Stock (AORT)Buy$1K – $15KAug 20
- ATRC AtriCure, Inc. - Common Stock (ATRC)Buy$1K – $15KAug 20
- BSX 150 Main Street Trust > Bank of America Boston Scientific Corporation Common StoBuy$1K – $15KAug 18
Fifty-eight transactions in one filing amount to a full portfolio rebuild: bigger-ticket buys in Microsoft, Eaton, Quanta Services and Globus Medical, funded partly by repeated Lamar Advertising sales and trims in AMD, Nvidia and Meta. The rotation leans toward power, infrastructure and medical devices while chip and ad-tech exposure comes down. Disclosed 37 days after the earliest trades.
Continue ReadingShow less
Gilbert Ray Cisneros, Jr. filed a single disclosure on September 10, 2026 covering trades made weeks earlier, with a lag of 37 days. Investors are seeing a rotation that is already complete.
The buying side tilts firmly toward power infrastructure and medical devices, with Microsoft, Eaton, Quanta Services, and Globus Medical representing the larger purchases. On the sell side, Lamar Advertising was trimmed repeatedly, while AMD, Nvidia, and Meta each saw partial sales, pulling down exposure to chips and ad-tech simultaneously.
Several of the purchases flowed through the 150 Main Street Trust held at Bank of America, covering names such as Amphenol, APi Group, Artivion, and Agios Pharmaceuticals. AtriCure was also added directly, reinforcing the medical-device lean across the portfolio.
The filing adds companies tied to electricity demand and surgical hardware while trimming positions linked to advertising and semiconductor exposure.